MARKET NEWS

Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease
Gerresheimer Establishes Small Series Production in the US
Soligenix COVID-19 Vaccine Boosts Neutralizing Activity Against SARS-CoV-2, Including Delta & Omicron 
Revel Pharmaceuticals Announces $8.4-Million Seed to Develop Repairing-Based Approaches to Reversing Aging
Catalent Biologics Completes $30-Million Project for Biopharmaceutical Development & Drug Product Manufacturing in Limoges, France
Viatris Announces Receipt of First FDA Approval for Generic Version of Symbicort Inhalation Aerosol in Partnership With Kindeva

  FEATURED EDITORIAL

  COMPANY PROFILE

Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety. Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services as well as a portfolio of injection, infusion, and primary packaging solutions. With decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to the latest stages of product commercialization, we help optimize critical aspects of parenteral drug delivery. Click here for more.


Ajinomoto Bio-Pharma Services Video Spotlight

  EXCLUSIVE ONLINE CONTENT

physIQ & CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

physIQ & CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

physIQ and CellCarta recently announced a strategic collaboration to undertake a groundbreaking study with the potential to revolutionize vaccine development…..

PAVmed Announces Successful First-in-Human Implantations of its Intraosseous Infusion System

PAVmed Announces Successful First-in-Human Implantations of its Intraosseous Infusion System

PAVmed Inc. recently announced physicians at the Clinica Porto Azul in Barranquilla, Colombia, successfully implanted the company’s PortIO Intraosseous Infusion System in three….

PathAI Partners With Datavant to Enable Biopharma Companies to Connect Digital Pathology Data for Research

PathAI Partners With Datavant to Enable Biopharma Companies to Connect Digital Pathology Data for Research

PathAI and Datavant recently announced a collaboration to enable compliant connectivity of PathAI’s pathology platform to life sciences trial data and other real-world data…..

Innoforce & Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies 

Innoforce & Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies 

Innoforce and Hibiscus BioVentures recently announced they have formed a strategic partnership to leverage the combined resources of both organizations to advance new Advanced Therapy Medicinal Products (ATMPs) and biologic medicines in order to….

Eyenovia Announces Positive Study Results Demonstrating its Optejet Delivery Technology Reduces Conjunctival Cell Toxicity From Preserved Ophthalmic Solutions to a Level Comparable With Non-Preserved Solutions

Eyenovia Announces Positive Study Results Demonstrating its Optejet Delivery Technology Reduces Conjunctival Cell Toxicity From Preserved Ophthalmic Solutions to a Level Comparable With Non-Preserved Solutions

Eyenovia, Inc. recently announced positive results from a research study conducted in collaboration with Dr. Pedram Hamrah, Interim Chairman of Ophthalmology at Tufts Medical Center, which evaluated the ocular surface….

  WHITEPAPERS & WEBINARS

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

This webinar will explore how to conduct effective extractables and leachables (E&L) testing on plastic process materials used during pharmaceutical and biopharmaceutical manufacturing…..

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

Emergent and groniger partner to present the benefits and features of the INTEGRA® high-speed aseptic fill line with isolator technology for viral vaccines and therapeutics.

  WHITEPAPERS & WEBINARS

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

WHITE PAPER: HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity

What techniques should manufacturers employ when working with low-dose drug products?

By: Thomas Daggs, MBA, Vice President, Product Development & Quality Control, and Angelo Consalvo, Director of Manufacturing, Enteris BioPharma

Anyone who takes an oral tablet medication – whether prescribed …

WHITEPAPER - Must-Use Strategies to Successfully Transfer & Scale Your Pharmaceutical Product

WHITEPAPER - Must-Use Strategies to Successfully Transfer & Scale Your Pharmaceutical Product

Introduction

Pharmaceutical companies are turning more frequently to external manufacturing partners for their development and production needs. A cornerstone of modern drug development strategy, contract development and manufacturing organizations (CDMOs) now produce about 28% of the world’s prescription and non-prescription …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 30- Polymers & Biomaterials
April 6 – Excipients